Acute neurologic deterioration in a patient with asymptomatic Charcot-Marie-Tooth disease following three doses of Brentuximab-Vedotin.
Haridian de la Nuez MeliánHugo Luzardo HenríquezAlexia Suárez CabreraRuth StuckeyMaría-Teresa Gómez-CasaresPublished in: Leukemia & lymphoma (2024)